Six New Medicaid Bulletin Articles Available as of April 7, 2020

The NC Division of Health Benefits has published six Medicaid Bulletin articles dated April 7, 2020:

• Antihemophilic Factor (Recombinant), Glycopegylated-Exei Lyophilized Powder for Solution, for Intravenous Use (Esperoct®) HCPCS Code J7199: Billing Guidelines
• Imipenem, Cilastatin, and Relebactam for Injection, for Intravenous Use (Recarbrio™) HCPCS Code J3490: Billing Guidelines
• Rituximab-Pvvr Injection, for Intravenous Use (Ruxience™) HCPCS Code J9999: Billing Guidelines
• Teprotumumab-Trbw for Injection, for Intravenous Use (Tepezza™) HCPCS Code J3590: Billing Guidelines
• NC Medicaid Electronic Health Record Incentive Program Announcements
• Bevacizumab-Bvzr Injection, for Intravenous Use (Zirabev™) HCPCS Code Q5118 - Injection, Bevacizumab-Bvzr, Biosimilar, (Zirabev), 10 mg: Billing Guidelines

Providers are encouraged to review this important information at https://medicaid.ncdhhs.gov/providers/medicaid-bulletin.